2,770
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Potential of modified Mediterranean diet to improve quality of life and fatigue severity in multiple sclerosis patients: a single-center randomized controlled trial

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1993-2004 | Received 21 Jun 2020, Accepted 16 Oct 2020, Published online: 08 Nov 2020

References

  • Bhargava, P.; Anthony, D. Metabolomics in Multiple Sclerosis Disease Course and Progression. Multi. Sclerosis J. 2020. DOI: 10.1177/1352458519876020.
  • Dolati, S.; Babaloo, Z.; Jadidi-Niaragh, F.; Ayromlou, H.; Sadreddini, S.; Yousefi, M. Multiple Sclerosis: Therapeutic Applications of Advancing Drug Delivery Systems. Biomed. Pharmacother. 2017, 86, 343–353.
  • Etemadifar M, Nikanpour Y, Neshatfar A, Mansourian M, Fitzgerald S. Incidence and prevalence of multiple sclerosis in persian gulf area: A systematic review and meta-analysis. Mult. Scler. Relat. Disord.. 2020 May 1;40:101959.
  • Palotai M, Cavallari M, Healy BC, Guttmann CR. A novel classification of fatigue in multiple sclerosis based on longitudinal assessments. Mult. Scler. J. 2020 May;26(6):725-34.
  • Sakoda, A.; Matsushita, T.; Nakamura, Y.; Watanabe, M.; Shinoda, K.; Masaki, K.; Isobe, N.; Yamasaki, R.; Kira, J.-I. Environmental Risk Factors for Multiple Sclerosis in Japanese People. Mult. Scler. Relat. Disord. 2020, 38, 101872. DOI: 10.1016/j.msard.2019.101872.
  • Jakimovski, D.; Weinstock-Guttman, B.; Gandhi, S.; Guan, Y.; Hagemeier, J.; Ramasamy, D. P.; Fuchs, T. A.; Browne, R. W.; Bergsland, N.; Dwyer, M. G. Dietary and Lifestyle Factors in Multiple Sclerosis Progression: Results from a 5-year Longitudinal MRI Study. J. Neurol. 2019, 266(4), 866–875. DOI: 10.1007/s00415-019-09208-0.
  • Marck, C. H.; Neate, S. L.; Taylor, K. L.; Weiland, T. J.; Jelinek, G. A. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors. PloS One. 2016, 11(2), e0148573. DOI: 10.1371/journal.pone.0148573.
  • Schwarz, S.; Leweling, H. Multiple Sclerosis and Nutrition. Mult. Scler. J. 2005, 11(1), 24–32. DOI: 10.1191/1352458505ms1119oa.
  • Swank, R.; Grimsgaard, A. Multiple Sclerosis: The Lipid Relationship. Am. J. Clin. Nutr. 1988, 48(6), 1387–1393.
  • Bradshaw MJ, Holick MF, Stankiewicz JM. Vitamin D and Multiple Sclerosis. In: Rizvi SA, Cahill JF, Coyle PK, editors. Clinical Neuroimmunology. Springer Nature Switzerland AG: Humana Press; 2020. p. 197-212.
  • Black, L. J.; Rowley, C.; Sherriff, J.; Pereira, G.; Ponsonby, A.-L.; Lucas, R. M. A Healthy Dietary Pattern Associates with A Lower Risk of A First Clinical Diagnosis of Central Nervous System Demyelination. Mult. Scler. J. 2019, 25(11), 1514–1525.
  • Reedy, J.; Subar, A.; George, S.; Krebs-Smith, S. Extending Methods in Dietary Patterns Research. Nutrients. 2018, 10(5), 571. DOI: 10.3390/nu10050571.
  • Galbete, C.; Schwingshackl, L.; Schwedhelm, C.; Boeing, H.; Schulze, M. B. Evaluating Mediterranean Diet and Risk of Chronic Disease in Cohort Studies: An Umbrella Review of Meta-analyses. Eur. J. Epidemiol. 2018, 33(10), 909–931. DOI: 10.1007/s10654-018-0427-3.
  • Sedaghat, F.; Jessri, M.; Behrooz, M.; Mirghotbi, M.; Rashidkhani, B. Mediterranean Diet Adherence and Risk of Multiple Sclerosis: A Case-control Study. Asia Pac. J. Clin. Nutr. 2016, 25(2), 377–384.
  • Silva P, Sureda A, Tur JA, Andreoletti P, Cherkaoui-Malki M, Latruffe N. How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?. Free Radical Res. 2019 Aug 12;53(sup1):1101-12.
  • Riccio, P.; Rossano, R. Nutrition Facts in Multiple Sclerosis. ASN Neuro. 2015, 7(1), 1759091414568185. DOI: 10.1177/1759091414568185.
  • Moravejolahkami, A. R.; Paknahad, Z.; Chitsaz, A. Association of Dietary Patterns with Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in MS Patients. Nutr. Neurosci. 2019, 1–11. doi:10.1080/1028415X.2019.1580831.
  • Kurtzke, J. F.;. Rating Neurologic Impairment in Multiple Sclerosis an Expanded Disability Status Scale (EDSS). Neurology. 1983, 33(11), 1444-1444. DOI: 10.1212/WNL.33.11.1444.
  • Association GAotWM. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. J. Am. College Dentists. 2014, 81(3), 14.
  • Riccio, P.; Rossano, R.; Larocca, M.; Trotta, V.; Mennella, I.; Vitaglione, P.; Ettorre, M.; Graverini, A.; De Santis, A.; Di Monte, E. Anti-inflammatory Nutritional Intervention in Patients with Relapsing-remitting and Primary-progressive Multiple Sclerosis: A Pilot Study. Experiment. Biol. Med. 2016, 241(6), 620–635.
  • Souri, E.; Amin, G.; Farsam, H.; Andaji, S. The Antioxidant Activity of Some Commonly Used Vegetables in Iranian Diet. Fitoterapia. 2004, 75(6), 585–588.
  • Willet, W.; Lenart, E. Reproducibility and Validity of Food-frequency Questionnaires. Monographs Epidemiol. Biostat. 1998, 1(30), 101–147.
  • Nematy, M.; Nouri, M.; Ghazizahedi, S.; Norouzy, A.; Mohajeri, S.; Shalaei, N.; Safariyan, M.; Esmaily, H. Validity and Reproducibility of Iranian Food Frequency Questionnaire. Switz Res. Park J. 2013, 102, 2137–2146.
  • Ghaem, H.; Haghighi, A. B.; Jafari, P.; Nikseresht, A. Validity and Reliability of the Persian Version of the Multiple Sclerosis Quality of Life Questionnaire. Neurol. India. 2007, 55(4), 369.
  • Pittion-Vouyovitch, S.; Debouverie, M.; Guillemin, F.; Vandenberghe, N.; Anxionnat, R.; Vespignani, H. Fatigue in Multiple Sclerosis Is Related to Disability, Depression and Quality of Life. J. Neurol. Sci. 2006, 243(1), 39–45.
  • Krupp, L. B.; LaRocca, N. G.; Muir-Nash, J.; Steinberg, A. D. The Fatigue Severity Scale: Application to Patients with Multiple Sclerosis and Systemic Lupus Erythematosus. Archiv. neurol. 1989, 46(10), 1121–1123. DOI: 10.1001/archneur.1989.00520460115022.
  • Jane Scott, P.; Huskisson, E. Measurement of Functional Capacity with Visual Analogue Scales. Rheumatology. 1977, 16(4), 257–259. DOI: 10.1093/rheumatology/16.4.257.
  • Azimian, M.; Shahvarughi Farahani, A.; Dadkhah, A.; Fallahpour, M.; Karimlu, M. Fatigue Severity Scale: The Psychometric Properties of the Persian-version in Patients with Multiple Sclerosis. Res. J. Biol. Sci. 2009, 4(9), 974–977.
  • Rotstein, D. L.; Cortese, M.; Fung, T. T.; Chitnis, T.; Ascherio, A.; Munger, K. L. Diet Quality and Risk of Multiple Sclerosis in Two Cohorts of US Women. Mult. Scler. J. 2019, 25(13), 1773–1780.
  • Moravejolahkami A, Chitsaz A. Mediterranean-Style Diet Co-Supplemented with Synbiotics Improved Quality of Life, Fatigue and Disease Activity in Five Secondary Progressive Multiple Sclerosis Patients. Ann. Med. & Surg. Case Rep: AMSCR. 2019;2019(02):1-3.
  • Sand, I. K.; Benn, E. K.; Fabian, M.; Fitzgerald, K. C.; Digga, E.; Deshpande, R.; Miller, A.; Gallo, S.; Arab, L. Randomized-controlled Trial of A Modified Mediterranean Dietary Program for Multiple Sclerosis: A Pilot Study. Mult. Scler. Relat. Disord. 2019, 36, 101403. DOI: 10.1016/j.msard.2019.101403.
  • Nellessen, A.; Nyamoya, S.; Zendedel, A.; Slowik, A.; Wruck, C.; Beyer, C.; Fragoulis, A.; Clarner, T. Nrf2 Deficiency Increases Oligodendrocyte Loss, Demyelination, Neuroinflammation and Axonal Damage in an MS Animal Model. Metabolic Brain Disease. 2020, 35(2), 353–362.
  • Chrysohoou, C.; Panagiotakos, D. B.; Pitsavos, C.; Das, U. N.; Stefanadis, C. Adherence to the Mediterranean Diet Attenuates Inflammation and Coagulation Process in Healthy Adults: The ATTICA Study. J. Am. Coll. Cardiol. 2004, 44(1), 152–158. DOI: 10.1016/j.jacc.2004.03.039.
  • Maric, T.; Woodside, B.; Luheshi, G. N. The Effects of Dietary Saturated Fat on Basal Hypothalamic Neuroinflammation in Rats. Brain Behav. Immun. 2014, 36, 35–45. DOI: 10.1016/j.bbi.2013.09.011.
  • Zhang S, Xue R, Hu R. The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction. European journal of nutrition. 2020 Jun;59(4):1295-311.
  • Brandes, M. S.; Gray, N. E. NRF2 as a Therapeutic Target in Neurodegenerative Diseases. ASN Neuro. 2020, 12, 1759091419899782.
  • Moravejolahkami AR, Paknahad Z, Chitsaz A. Dietary intake of energy and fiber in MS patients; an approach to prebiotics role. Nutr. & Food Sci. 2019;49(06):1039-50.
  • Khangwal, I.; Shukla, P. Potential Prebiotics and Their Transmission Mechanisms: Recent Approaches. J. Food Drug Anal. 2019, 27(3), 649–656.
  • Varney, J.; Muir, J. G.; Gibson, P. R. Prebiotics versus Low FODMAP Diet: An Interpretative Nightmare. Gastroenterology. 2019, 156(4), 1222. DOI: 10.1053/j.gastro.2018.10.060.
  • Jovanovic-Malinovska, R.; Kuzmanova, S.; Winkelhausen, E. Oligosaccharide Profile in Fruits and Vegetables as Sources of Prebiotics and Functional Foods. Int. J. Food Prop. 2014, 17(5), 949–965. DOI: 10.1080/10942912.2012.680221.
  • San Andres, J. V.; Sambeek, D.; Kinstler, S.; Trenhaile-Gannemann, M.; Winkel, S.; Schlageter-Tello, A.; Miller, P.; Burkey, T. E. PSVII-19 Potential Biomarkers of Intestinal Injury and Inflammation in Nursery Pigs Fed Prebiotics. J. Anim. Sci. 2019, 97(Supplement_2), 220-220. DOI: 10.1093/jas/skz122.388.
  • Fan, Y.; Zhang, J. Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front. Microbiol. 2019, 10, 740. DOI: 10.3389/fmicb.2019.00740.